
By Christine Graf
Medical device manufacturer AngioDynamics is experiencing a decline in sales as a result of the COVID-19 pandemic.
In the three months prior to the pandemic, the company reported sales of $69.8 million. This represented a 6.5 percent increase compared to the prior-year quarter, according to the company. The growth was in all three of its business units—oncology, vascular interventions and therapies, and vascular access.
Officials said sales for medical device manufacturers began to plummet after hospitals were forced to postpone non-essential surgeries—surgeries that are able to be delayed without placing undue risk to the current or future health of a patient. These surgeries typically account for 40 to 50 percent of revenue at U.S. hospital.
“Because our customers are healthcare providers, many of the cases we support have been reclassified as elective,” said AngioDynamics communications director Saleem Cheeks.